OGN Organon & Co

  1. Stocks
  2. Healthcare
  3. NYSE: OGN

Price (delayed)

$13.72

Market cap

$3.6B

P/E Ratio

17.37

Dividend/share

$0.08

EPS

$0.79

Enterprise value

$11.02B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 59
Highlights
The equity is up by 37% YoY and by 11% QoQ
The quick ratio has grown by 35% YoY
The price to earnings (P/E) is 163% more than the 5-year quarterly average of 6.6 and 77% more than the last 4 quarters average of 9.8
The company's EPS has shrunk by 71% YoY and by 16% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Peers: OPK ORGO

Key stats

What are the main financial stats of OGN

OGN stock price

How has the Organon stock price performed over time
Intraday
0%
1 week
0.88%
1 month
1.63%
1 year
46.11%
YTD
91.35%
QTD
1.33%

Financial performance

How have Organon's revenue and profit performed over time
Revenue
$6.13B
Gross profit
$3.23B
Operating income
$824M
Net income
$209M
Gross margin
52.7%
Net margin
3.4%
Organon's net income has plunged by 70% YoY and by 15% from the previous quarter
Organon's net margin has plunged by 69% YoY and by 15% from the previous quarter
The company's operating income fell by 30% YoY
OGN's operating margin is down by 29% year-on-year

Price vs fundamentals

How does OGN's price correlate with its fundamentals

Growth

What is Organon's growth rate over time

Valuation

What is Organon stock price valuation
OGN P/E details
P/E
17.37
P/B
3.58
P/S
0.59
EV/EBIT
11.5
EV/EBITDA
8.4
EV/Sales
1.8
The price to earnings (P/E) is 163% more than the 5-year quarterly average of 6.6 and 77% more than the last 4 quarters average of 9.8
The company's EPS has shrunk by 71% YoY and by 16% QoQ
The equity is up by 37% YoY and by 11% QoQ
The P/B is 33% more than the last 4 quarters average of 2.7
The price to sales (P/S) is 48% higher than the last 4 quarters average of 0.4 but 26% lower than the 5-year quarterly average of 0.8
The revenue has declined by 2.5% year-on-year

Efficiency

How efficient is Organon business performance
The return on equity has dropped by 81% year-on-year and by 22% since the previous quarter
The ROA has dropped by 70% year-on-year and by 16% since the previous quarter
The return on invested capital has declined by 20% year-on-year and by 6% since the previous quarter
The company's return on sales fell by 16% YoY and by 6% QoQ

Dividends

What is OGN's dividend history
Dividend details
DPS
$0.08
Dividend yield
0.58%
Payout ratio
10.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Organon financials performed over time
OGN's total assets is 8% more than its total liabilities
The quick ratio has grown by 35% YoY
OGN's current ratio is up by 18% year-on-year
The equity is up by 37% YoY and by 11% QoQ
The debt to equity has contracted by 30% YoY and by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.